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a b s t r a c t
The primary objectives of this study were to validate a canine relaxin RIA for use in otariids and phocids
and consider practical applications. For 6 captive Northern fur seal females, serum samples were grouped
and examined according to pregnancy (n = 13), post-partum (n = 8) and non-pregnancy (n = 6), and, for 2
captive Northern fur seal males, serum samples were grouped and examined together regardless of age
(2 mo–15 yrs, n = 6). Placental tissue was available for examination from one Northern fur seal, Steller sea
lion and harbor seal. The validation process involved several steps using an acid-acetone extraction process to isolate a relaxin-containing fraction in pools of serum from each group of fur seals and placental
tissue from each seal species. A relaxin-like substance was detected in extracts of pregnant, non-pregnant
and male serum and placental tissue in a dose-responsive manner as increasing volumes of respective
extracts or amounts of canine relaxin were introduced into the assay. In raw serum samples, mean
immuno-reactive relaxin concentrations were higher (P < 0.05) during pregnancy than post-partum
and non-pregnancy, and lower (P < 0.05) in male than female fur seals. During pregnancy, mean serum
concentrations of relaxin progressively increased (P < 0.05) over Months 4–10 and, in serial samples collected from the same fur seals before and after parturition, mean concentrations were higher (P < 0.06)
pre-partum than post-partum. In conclusion, validation of a homologous canine relaxin RIA for use in
otariids and phocids resulted in the discovery of a relaxin-like substance in extracted and raw serum
and placental tissue from Northern fur seals, a Steller sea lion and harbor seal. Distinctly higher
immuno-reactive concentrations during pregnancy indicated the potential for relaxin to serve as a hormonal marker to differentiate between pregnant and non-pregnant or pseudopregnant pinnipeds.
Published by Elsevier Inc.

1. Introduction
In 1988 the US National Marine Fisheries Service (NMFS) declared the stock of Eastern Paciﬁc Northern fur seals (Callorhinus
ursinus) of the Pribilof Islands (St Paul and St George), Alaska as depleted under the Marine Mammal Protection Act (NMFS, 2007).
The basis for the population decline is not fully known but likely
involves a combination of natural (e.g., disease, predator-prey)
and human-related (e.g., sea debris, endocrine disruptors) factors
that have had a direct and indirect effect on reproduction. Our cur-
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rent understanding of reproductive physiology in fur seals is rudimentary since most of what is known comes from a few early
studies where seals were captured at sea and on land at different
times during their reproductive cycles, euthanized and necropsied
(reviews, Daniel, 1981; Boyd, 1991; Atkinson, 1997; Boyd et al.,
1999). Apart from terminal studies, there are only a few later studies that have collected reproductive data in a longitudinal manner
in other otariids (Gales et al., 1997; Greig et al., 2007; VillegasAmtmann et al., 2009). To clarify the nature of the population decline and for planning mitigation strategies in Northern fur seals
and other threatened otariid and phocid populations, there is a
need to establish a contemporary and comprehensive data base
of pinniped reproductive physiology using nonlethal techniques.
Implantation and development of the placenta is a pivotal event in
the survival of the early embryo, yet it is one of the least understood
aspects of reproduction in mammals (review, Cross et al., 1994).
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Implantation failure accounts for almost 80% of early embryonic loss
that occurs in domestic animals (Roberts et al., 1990, 1992; King,
1991). Although the pregnancy loss rate in Northern fur seals preand post-embryonic diapause is not known, approximately 88% of
603 multiparous females collected at sea and examined post-mortem
had evidence of implantation of which approximately 1.6% of the
pregnant females apparently aborted a fetus (York and Scheffer,
1997). For the remaining fur seals, implantation either failed (i.e., no
evidence of implantation) or the early embryo was overlooked.
Relaxin is a 6-kDa polypeptide related to the insulin family of
hormones and growth factors (review, Park et al., 2005). In most
species studied, the embryo/feto-placental unit is the greatest
source of relaxin production. In some species (reviews, Hayes,
2004; Sherwood, 2004; Park et al., 2005), relaxin is also produced
to a lesser extent by other reproductive organs in females (e.g.,
ovaries, uterus) and males (e.g., testes, prostate) as well as in
non-reproductive organs (e.g., heart, kidneys). Relaxin is well
known to have an effect in humans and laboratory and domestic
animals during late pregnancy as a hormone responsible for relaxation of the cervix and pelvic ligaments in association with parturition (review, Dschietzig and Stangl, 2003). Less well known is the
role relaxin plays during early pregnancy when non-placental
sources of relaxin signal remodeling of the uterine stroma and vasculature and the production of factors that promote trophoblast
adherence to and invasion of the endometrium (Dschietzig and
Stangl, 2003; Hayes, 2004; Sherwood, 2004; Park et al., 2005). In
this regard, disruption of relaxin production during early pregnancy has been associated with embryo/fetal loss in humans and
primates (Stewart et al., 1993; Einspanier et al., 1999).
In veterinary medicine, immunoassay and detection of elevated
systemic relaxin concentrations is a diagnostic indicator of pregnancy and differential measure to distinguish between pregnant
and pseudopregnant dogs (Steinetz et al., 1989) since progesterone
concentrations are not distinctly different between pregnant and
non-pregnant bitches (review, Johnston et al., 2001). Reportedly
(Sherwood, 2004), there has been limited (<76%) evolutionary conservation of the amino acid sequence of relaxin among the more than
25 species in which the sequence of relaxin is known. Nevertheless,
canine as well as porcine and equine radioimmunoassays (RIA) have
been used to detect immuno-reactive relaxin in association with
pregnancy in the serum of spotted hyenas (Steinetz et al., 1997), llamas (Bravo et al., 1996), rhinoceroses and elephants (Steinetz et al.,
2005), in the plasma of coyotes (Carlson and Gese, 2007), and in
the serum and urine of domestic and non-domestic cats (Stewart
and Stabenfeldt, 1985; de Haas van Dorsser et al., 2006). Immunoreactive relaxin has also been detected in placental tissue of the spotted hyena (Steinetz et al., 1997). Considering these results, relaxin has
been proposed as a potential hormonal marker of pregnancy in wild
animal species (reviews, Steinetz et al., 2005, 2009).
Anatomically, the chorio-allantoic placenta of pinnipeds is comparable to many other carnivores (Harrison et al., 1952). For example, canids and pinnipeds have zonary, endothelio-chorial
placentation (Craig, 1964; Miglino et al., 2006). Considering the
evolutionary proximity of these species, a previously validated canine relaxin RIA (Steinetz et al., 1996) was chosen to attempt validation for use with pinnipeds and investigate the potential of
relaxin to serve as a hormonal marker of pregnancy in otariids
and phocids. It is expected that a relaxin RIA for use in pinnipeds
will provide a nonlethal and repeatable approach to study the basic
physiology of uterine–conceptus–ovarian interactions during the
peri-implantation period at the end of embryonic diapause and
serve as a diagnostic tool for detecting pregnancy status in captive
and free-ranging otariids and phocids for conservation and reproductive management purposes.
The primary objectives of this study were to validate a canine
relaxin RIA for use with serum from Northern fur seals, test the

hypothesis that immuno-reactive relaxin concentrations are higher
in pregnant than in non-pregnant fur seals and consider practical
applications. Secondarily, placental tissue samples from a Northern
fur seal, Steller sea lion (Eumetopias jubatus) and harbor seal (Phoca
vitulina) were included in the study, in part, to supplement the assay validation process and provide preliminary information on the
source of relaxin in otariids and phocids.
2. Materials and methods
2.1. Animals and serum samples
Northern fur seals from which the serum samples were collected and used in the present study were in residence at Mystic
Aquarium (Mystic, CT, USA). All 6 females were captured and
moved from St Paul Island, Alaska as young adults in the summer
of 1984, whereas the 2 males were born in captivity in 1988 and
2003. Seals were housed and fed in compliance with the US Animal
Welfare Act and standard aquarium management practices for
pinnipeds, which included a US Department of Agriculture-approved Program of Veterinary Care for the regular collection of
blood to monitor health status and to assess apparent health issues. Blood samples were collected periodically from 1989–2007
from males throughout growth and development (e.g., pre- and
post-puberty) and females during various reproductive states
(e.g., estrous cycle and pregnancy). Blood samples were taken under manual restraint from an interdigital vein in the webbing of the
hind ﬂipper using a 20-gauge, 2.54 cm needle on a 12 cc eccentrictip syringe. Blood from each seal was placed in a 10-ml serum separator tube and processed for clinical chemistry. Remaining serum
(1–2 ml) from each seal was transferred to a separate cryo-vial, labeled with seal identiﬁcation and date, and archived at 60 °C. Archived serum samples were selected and shipped frozen to a
laboratory at New York University School of Medicine (Tuxedo,
NY, USA) and stored at 20 °C until assay.
Serum samples from adult female fur seals were grouped
according to reproductive status: (1) pregnancy (blood collected
from 4–12 mo of gestation, n = 13 samples), (2) post-partum (blood
collected from 4 d–5 mo after parturition, n = 8 samples) and (3)
non-pregnancy (blood collected over 12-mo reproductive cycles,
n = 6 samples). Samples from male fur seals were grouped together
regardless of age (blood collected from 2 mo–15 yrs, n = 6 samples). In addition, samples from the pregnancy group were subgrouped according to months of pregnancy: (1) Months 4–5
(n = 2 samples), (2) Months 7–8 (n = 4 samples) and (3) Months
9–10 (n = 6 samples). Month of pregnancy was determined retrospectively from day of parturition. The non-pregnancy group included samples from non-bred and bred seals and was deﬁned
according to the absence of a pup after a 12-mo reproductive cycle.
Samples that were associated with a known pregnancy that was
subsequently lost were not included in the non-pregnancy group.
Since there was a limited amount of serum in individual samples,
portions of serum were collected from multiple samples within
respective groups and combined into separate pools for acid-acetone extraction to isolate a relaxin-containing fraction and test
for immuno-reactivity in the validation process.
2.2. Placental tissue samples
Northern fur seal, Steller sea lion and harbor seal placentae
were collected and made available according to respective permits
issued under the US Marine Mammal Protection Act. From the California Marine Mammal Center (Sausalito, CA, USA), a placenta was
collected after stillbirth from a stranded Northern fur seal in March
2007 from which a tissue sample was cut and frozen ( 80 °C).
From the Alaska SeaLife Center (Seward, AK, USA), placentae were
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collected and frozen ( 20 °C) after necropsy of a recently deceased
free-ranging Steller sea lion and after birth from a captive harbor
seal in May 2008. The fur seal placental tissue sample and sea lion
and harbor seal placentae were shipped frozen to a laboratory at
New York University School of Medicine (Tuxedo, NY, USA) and
stored at 20 °C until further processing and assay.
Tissue samples from each seal placenta were processed for assay of relaxin in a comparable manner to that described for the
spotted hyena placenta (Steinetz et al., 1997). Brieﬂy, a 15 g sample
previously cut from the fur seal placenta, and 250 g samples cut
from a site most representative (darkest red) of the zonary or vascular portion of the sea lion and harbor seal placentae were
homogenized in cold phosphate buffered saline (PBS), centrifuged
and decanted to remove tissue fragments and fat. Supernatants
of the placental tissue samples were set aside for acid-acetone
extraction to isolate a relaxin-containing fraction and test for immuno-reactivity in the validation process.
2.3. Acid-acetone extraction of serum pools and placental tissue
supernatants
Many polypeptides are precipitated by acidiﬁed acetone, but relaxin is a relatively small and highly stable protein that is soluble in
acid-acetone (Steinetz et al., 1962). Extraction in acidiﬁed acetone
separates small polypeptides from larger, acetone-insoluble proteins that are predominant in blood and other tissues, which could
potentially interfere with immuno-reactivity in the relaxin RIA.
The acid-acetone extraction process used herein has been described (Doczi, 1963) and previously used to isolate the relaxincontaining fraction from placental tissue of the spotted hyena to
verify immuno-reactivity in the canine relaxin assay (Steinetz
et al., 1997). Brieﬂy, serum pooled from pregnant (2.0 ml), nonpregnant (8.5 ml) and male (7.0 ml) fur seals and supernatants of
homogenized placental tissue from each seal species were mixed
with water, concentrated HCl and 70% (v/v) acetone at 4 °C for
approximately 24 h. Afterwards, respective mixtures were ﬁltered
and precipitated with additional cold acetone (90%, v/v). Approximately 24 h later, the acetone supernatants were removed and
respective relaxin-containing fractions were dried and reconstituted with assay buffer and set aside until assay.
2.4. Relaxin assay
Details of a previously validated canine relaxin RIA have been
described (Steinetz et al., 1996). In the present study, 3 antibodies
developed against relaxin were initially tested for immuno-reactivity to a relaxin-like substance in raw serum from a pregnant
Northern fur seal: (1) rabbit polyclonal porcine relaxin antiserum
R6 which reacts speciﬁcally with the receptor binding domain of
all relaxins thus far sequenced (O’Byrne and Steinetz, 1976), (2)
rabbit polyclonal canine relaxin antiserum No. 79888 which is
highly reactive with relaxin in canids and felids (Steinetz et al.,
1996; de Haas van Dorsser et al., 2006), and (3) rabbit polyclonal
canine relaxin antiserum No. 80037 (Steinetz et al., 1996). Speciﬁc
binding was approximately 12% with antiserum No. 80037 in pregnant fur seal serum compared to little or no detectable immunoreactivity with the other antisera in the same pregnant fur seal
sample. Hence, a homologous canine relaxin RIA was used in the
present study which included canine antiserum No. 80037 as the
primary antibody (working dilution, 1:5000) and synthetic canine
relaxin as reference standard (0.1–12.5 ng/tube) and 125I-labeled
ligand (approximately 30,000 cpm/tube).
Veriﬁcation of the canine relaxin RIA for use with serum and
placental tissue from Northern fur seals and a Steller sea lion and
harbor seal included several validation steps following acid-acetone extraction: (1) isolation and immuno-reactivity of a relaxin-
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like substance in extracts from pools of pregnant, non-pregnant
and male serum and placental tissue from each seal species, (2)
speciﬁc displacement of radiolabeled canine relaxin from the canine relaxin antibody by increasing volumes (100 and 200 ll) of
extract from pools of pregnant, non-pregnant and male serum
and placental tissue from each seal species, and (3) additivity by
adding increasing amounts of canine relaxin (0, 0.8 and 1.6 ng) to
an extract of pooled male fur seal serum or assay buffer.
Extracts of pooled serum and placental tissue samples from
Northern fur seals and a Steller sea lion and harbor seal and raw
serum samples from individual fur seals were assayed for immuno-reactive relaxin using 100 or 200 ll of extracts in assay buffer
or 200 ll of raw serum in duplicate. The results were expressed
as the average speciﬁc binding or concentration of duplicates relative to the canine relaxin reference standard. Assay sensitivity was
set at 90% of speciﬁc binding (approximately 0.6 ng/ml) and intraand inter-assay coefﬁcients of variation were 5% and 15%,
respectively.
2.5. Statistical analyses
Prior to statistical analyses, the data were checked for extreme
values using Dixon’s outlier test (Kanji, 1993), tested for homogeneity and transformed if necessary. Analysis of variance was used
to determine differences in serum concentrations of immuno-reactive relaxin among groups (pregnant, post-partum and non-pregnant and male fur seals) and months of pregnancy (4–5, 7–8, and
9–10). If there was a signiﬁcant effect, independent t-tests were
used to identify mean differences among groups or months. In serial samples collected repeatedly from the same fur seals before
and after parturition, a paired t-test was used to compare mean
differences in serum relaxin concentrations pre- and post-partum.
A probability of P 6 0.05 indicated that a difference was signiﬁcant
and probabilities between P > 0.05 and 0.1 indicated that a difference approached signiﬁcance. Values are reported as mean ± SEM
unless otherwise indicated.
3. Results
Validation results following acid-acetone extraction of pools of
serum and placental tissue from Northern fur seals and a Steller
sea lion and harbor seal are shown for each step in Table 1. The
acid-acetone extraction process with the fur seal placental tissue
sample yielded a relaxin-containing fraction that was sufﬁcient
to examine duplicate volumes of 100 ll but not 200 ll of extract
(Table 1, Step 2). Compared with 250 g samples of placental tissue
from the sea lion and harbor seal, a 15 g sample of placental tissue
from the fur seal was inadequate to complete the dose-responsive
displacement of radiolabeled canine relaxin from the canine
antibody.
Mean immuno-reactive relaxin concentrations in raw serum
samples from groups of pregnant, post-partum, non-pregnant
and male fur seals are shown with statistical results in Table 2.
For serial samples collected repeatedly from the same fur seals
pre- and post-partum, individual and mean results are shown with
statistical results in Table 3. Inspection of the individual results
indicated relaxin concentrations declined after parturition in 3 of
the 4 seals. In Seal A, the relaxin value during pregnancy in 1989
was uncharacteristically low compared to the concentration at
approximately the same stage of gestation in the subsequent year,
and in comparison to values in other seals in the pregnant group
(Table 3). Consequently, the aberrant value reduced the statistical
signiﬁcance between mean concentrations of relaxin pre- and
post-partum.
Mean immuno-reactive relaxin concentrations in fur seals
sub-grouped according to months of pregnancy are shown with
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Table 1
Validation steps for verifying a homologous canine relaxin RIA for use in otariids and phocids.
Step 1.

Immuno-reactivity in relaxin-containing fractions following acid-acetone extraction of pooled serum and placental tissue from each seal species.
Relaxin
Acid-acetone extraction

Pregnant pool

Non-pregnant pool

Male pool

Fur seal serum (ng/ml)

42.7

17.2

5.0

Northern fur seal

Steller sea lion

Harbor seal

200

1600

292

Placental tissue (ng/kg)
Step 2.

Speciﬁc displacement of radiolabeled relaxin binding in response to increasing volumes of acid-acetone extracts of pooled serum or placental tissue from each seal
species.
Speciﬁc binding (%)

Step 3.

Northern fur seal serum
Extract volume (ll)

Pregnant pool

Non-pregnant pool

Male pool

100
200

59
44

75
61

83
76

Placental tissue
Extract volume (ll)

Northern fur seal

Steller sea lion

Harbor seal

100
200

76
*

73
61

87
74

Additivity and speciﬁc displacement of radiolabeled relaxin binding by adding increasing amounts of canine relaxin standard to an acid-acetone extract of pooled
male Northern fur seal serum or assay buffer.
Speciﬁc binding (%)
Canine relaxin (ng/ml)

Seal serum

Assay buffer

0.0
0.8
1.6

66
53
46

100
66
52

* Placental tissue sample (15 g) was insufﬁcient to prepare an adequate amount of extract for assay at greater volume.

Table 2
Mean (±SEM) immuno-reactive relaxin concentrations in raw serum samples grouped
according to pregnant, post-partum and non-pregnant females (6) and male (2)
Northern fur seals.
Groups

No. samples

Relaxin (ng/ml)1

Pregnant
Post-partum
Non-pregnant
Male

13
8
6
6

8.2 ± 1.5a
3.6 ± 1.0b
2.5 ± 0.4b
1.1 ± 0.2c

Table 4
Mean (±SEM) immuno-reactive relaxin concentrations in raw serum samples from
pregnant Northern fur seals (6) sub-grouped according to month of pregnancy. Month
of pregnancy was determined retrospectively from day of parturition.
Serum sample

Number
Relaxin (ng/ml)1

Months of pregnancy
4–5

7–8

9–10

2
0.8 ± 0.0a

4
7.1 ± 1.8b,x

6
11.1 ± 2.1b,y

1

Month effect, P < 0.05.
Values differ, P < 0.04.
x,y
Values differ, P < 0.1.

1

Group effect, P < 0.002.
Values differ, P < 0.05.

a,b

a,b,c

Table 3
Individual and mean concentrations of immuno-reactive relaxin in raw serum from
Northern fur seals pre- and post-partum for two consecutive reproductive cycles for
Seal A and one reproductive cycle each for Seals B and C.
Pre-partum

Post-partum

Seal

Yr

Time

Relaxin (ng/ml)

Time

Relaxin (ng/ml)

A
A
B
C

1989
1990
1989
1990

4
5
4
3

3.7
12.1
7.4
10.1

1
1
4
5

5.1
4.2
2.3
0.8

mo
mo
mo
mo

Mean ± SEM
a,b

8.4 ± 1.8a

mo
mo
d
mo

3.1 ± 1.0b

Values differ, P < 0.06.

statistical results in Table 4. Although there was a signiﬁcant effect of
month as a result of a progressive increase in mean concentrations of
relaxin during gestation, the data should be interpreted cautiously
because of the small number of samples and concentrations that
were near the sensitivity of the assay, especially during Months 4–5.
4. Discussion
The availability of archived serum samples collected from captive Northern fur seals and placental tissue from a free-ranging

Northern fur seal, Steller sea lion, and captive harbor seal provided
the opportunity to adapt and validate a homologous canine relaxin
RIA for the discovery of a relaxin-like substance in pinnipeds. The
pelagic nature of fur seals (Atkinson, 1997; Boyd et al., 1999) and
regulatory criteria under the Marine Mammal Protection Act
(NMFS, 2007) preclude systematic collection of blood samples
from free-ranging seal pups, juveniles and adults during growth
and reproduction. Aquariums have played a historic role in the
conservation of fur seals, and periodic collection of blood samples
is a routine part of management practices. Even though the number of captive fur seals that have been conditioned for the collection of blood is limited to a few seals and aquariums (e.g.,
Mystic, CT and Seattle, WA, USA), availability of numerous serum
samples archived over multiple years can provide a reasonable distribution of samples for examination during pre- and post-puberty
and various stages of the estrous cycle, pregnancy and post-partum. Although the effect of long-term cryopreservation on serum
concentrations of relaxin is unknown, it is known that relaxin is
a stable and soluble protein hormone in acid-acetone that can
withstand exposure to extreme cold, heat and long periods at
ambient temperature (Steinetz et al., 1962; Doczi, 1963). In the
present study, freezer storage times and conditions were similar
among archived pregnant, non-pregnant, and male fur seal
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samples; therefore, any alteration (i.e., decline) in serum relaxin
concentrations due to prolonged storage would presumably be
proportional among samples. Thus, this study represents an
unprecedented collaboration among a diverse group of scientists
from government, academia and aquatic institutes to develop a
comprehensive data base for reproductive hormones in Northern
fur seals that may serve as a future source of reference for samples
taken from captive as well as free-ranging fur seals and other otariids and phocids.
The canine relaxin RIA has been fully validated for use in dogs
(Steinetz et al., 1996) and successfully validated and adapted for
use in a variety of wildlife species primarily as a noninvasive approach to distinguish pregnant from non-pregnant or pseudopregnant animals (Steinetz et al., 2005, 2009). In the present study,
acid-acetone extraction (Doczi, 1963; Steinetz et al., 1997) was
used to isolate a relaxin-like substance in pools of serum from female (pregnant and non-pregnant) and male Northern fur seals
and placental tissue from a Northern fur seal, Steller sea lion and
harbor seal. Assay of the relaxin-containing fractions indicated relatively high, intermediate and low serum concentrations of immuno-reactive relaxin in pregnant, non-pregnant and male fur seals,
respectively. Immuno-reactive relaxin was also detected in the placenta of each seal species. There was a dose-responsive displacement of radiolabeled canine relaxin from the canine antibody as
increasing volumes of extracts from respective serum pools or placental tissue were introduced into the assay. A dose-responsive
displacement of radiolabeled canine relaxin was also observed as
increasing amounts of the canine relaxin reference standard were
added to the relaxin-containing fraction of male fur seal serum.
When compared with the same amount of canine relaxin added
to assay buffer, speciﬁc binding was lower (12–34%) for the extract
than buffer at each level, which was attributed to the additive effect of a relaxin-like substance in male seal serum.
Although the acid-acetone extraction process was inefﬁcient
requiring a relatively large volume (2–8 ml) of pooled serum from
individual samples from pregnant, non-pregnant and male Northern fur seals, the process was effective and fundamental for validation of the canine relaxin assay for use with fur seal serum. It was
not thoroughly known beforehand if components of raw serum
would interfere with immuno-reactivity in the relaxin assay. Nevertheless, the extraction process was not practical for the relatively
small volume of serum remaining in individual fur seal samples.
In raw serum samples, mean concentrations of immuno-reactive
relaxin were signiﬁcantly higher in pregnant than in non-pregnant
or post-partum fur seals, and signiﬁcantly lower in males than
females. Temporally, there was a progressive increase in mean concentrations of relaxin from relatively low values during Months 4–5
to signiﬁcantly higher values during Months 9–10. In serial samples
collected from the same fur seals before and after parturition, mean
relaxin concentrations were higher pre-partum than post-partum.
The directional changes in serum relaxin from relatively high concentrations during pregnancy to low concentrations after parturition and during non-pregnancy in fur seals is similar to that
reported in dogs (Johnston et al., 2001), horses (Ginther, 1992), pigs
(Dlamini et al., 1995), laboratory rodents (Sherwood, 1994), camelids (Bravo et al., 1996) and wild animal species (Steinetz et al.,
2005, 2009). Taken together, raw serum from pregnant, non-pregnant (post-partum) and male fur seals did not appear to interfere
with detection of relaxin based on comparable relative changes
among extracts of pooled serum from corresponding groups in the
validation process. Moreover, the combined results supported the
hypothesis that immuno-reactive relaxin concentrations are higher
in pregnant than in non-pregnant Northern fur seals.
In the present study, the relatively low serum concentrations of
immuno-reactive relaxin during Months 4–5 of pregnancy corresponds to the end of embryonic diapause, a period of delayed
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implantation that reportedly ranges from 3–5 months in Northern
fur seals (Daniel, 1981; Boyd, 1991; Atkinson, 1997; Boyd et al.,
1999) following ovulation primarily in July (Craig, 1964). However,
the lack of samples during diapause and small number of samples
thereafter preclude a detailed understanding of any temporal relationship between relaxin and the peri-implantation period in fur
seals at this time. Later, during pregnancy, serum concentrations
of relaxin were relatively higher and apparently of placental origin.
Although low, the source of relaxin in non-pregnant and male fur
seals is not known. In species other than pinnipeds, reproductive
(e.g., ovaries, uterus, mammary glands, testes, prostate) and nonreproductive organs (e.g., brain, heart, kidneys) have been identiﬁed as non-placental sources of relaxin (Hayes, 2004; Sherwood,
2004; Park et al., 2005). Future studies are needed to critically
examine the changes in circulating concentrations of relaxin
encompassing the end of embryonic diapause and identify and
conﬁrm placental and non-placental sources of relaxin in female
and male Northern fur seals and other otariids and phocids of both
genders.
Knowledge of relative changes in circulating concentrations of
relaxin has both basic and applied implications. From a basic perspective, results of immunoassay of relaxin in combination with results from ultrasonic imaging of the uterus, conceptus and ovaries in
pinnipeds (Adams et al., 2007) can further our understanding of
functional and structural relationships at the end of embryonic diapause and survival of the early embryo during implantation in a nonlethal manner. From an applied perspective, assay of relaxin may be
a more effective hormonal indicator than progesterone to distinguish between pregnant and non-pregnant or pseudopregnant
otariids and phocids. In general, it is thought that the corpus luteum
in pregnant seals is maintained throughout gestation, but may regress before parturition in some species of pinnipeds (Daniel,
1981; Boyd, 1991; Atkinson, 1997; Boyd et al., 1999). Comparatively,
in non-pregnant seals, it is thought that functional and structural
development of the corpus luteum is similar to that during the period of delayed implantation but, thereafter, it gradually regresses in
the absence of placental luteotrophic support (Boyd et al., 1999). The
condition of elevated concentrations of progesterone in non-pregnant seals that appears to mimic the condition in pregnant seals
has been referred to as pseudopregnancy (Atkinson, 1997; Boyd
et al., 1999), which seems comparable to the condition reported in
dogs (Johnston et al., 2001). Until functional and structural development of the corpus luteum has been thoroughly characterized in
pregnant and non-pregnant pinnipeds, the results of immunoassay
of circulating concentrations of progesterone as a hormonal indicator of pregnancy will be equivocal. Alternatively, results of the present study indicate that elevated concentrations of immuno-reactive
relaxin are pregnancy-speciﬁc; hence, relaxin has the potential to
serve as an effective hormonal marker for diagnosing pregnancy in
otariids and phocids as it is in canids and other species (Steinetz
et al., 2005, 2009).
In conclusion, validation of a homologous canine relaxin RIA for
use in otariids and phocids resulted in the discovery of a relaxinlike substance in extracted and raw serum and placental tissue
from Northern fur seals, a Steller sea lion and harbor seal. Distinctly higher immuno-reactive concentrations during pregnancy
indicated the potential for relaxin to serve as a hormonal marker
to differentiate between pregnant and non-pregnant or pseudopregnant pinnipeds.
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